[go: up one dir, main page]

MXPA05011671A - Nuevos derivados de anilina, su manufactura y su uso como agentes farmaceuticos. - Google Patents

Nuevos derivados de anilina, su manufactura y su uso como agentes farmaceuticos.

Info

Publication number
MXPA05011671A
MXPA05011671A MXPA05011671A MXPA05011671A MXPA05011671A MX PA05011671 A MXPA05011671 A MX PA05011671A MX PA05011671 A MXPA05011671 A MX PA05011671A MX PA05011671 A MXPA05011671 A MX PA05011671A MX PA05011671 A MXPA05011671 A MX PA05011671A
Authority
MX
Mexico
Prior art keywords
manufacture
pharmaceutical agents
aniline derivatives
novel aniline
novel
Prior art date
Application number
MXPA05011671A
Other languages
English (en)
Inventor
Matthias Rueth
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33395779&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA05011671(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MXPA05011671A publication Critical patent/MXPA05011671A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invencion describe los compuestos de formula (I) (ver formula (I)), sus sales farmaceuticamente aceptables, formas enantiomericas, diastereoisomeros, y racematos, la preparacion de los compuestos anteriormente mencionados, medicamentos que los contienen y su fabricacion, asi como el uso de los compuestos anteriormente mencionados, en el control o la prevencion de enfermedades tales como cancer.
MXPA05011671A 2003-04-30 2004-04-29 Nuevos derivados de anilina, su manufactura y su uso como agentes farmaceuticos. MXPA05011671A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03009908 2003-04-30
PCT/EP2004/004520 WO2004096796A1 (en) 2003-04-30 2004-04-29 Novel aniline derivatives, their manufacture and use as pharmaceutical agents

Publications (1)

Publication Number Publication Date
MXPA05011671A true MXPA05011671A (es) 2005-12-15

Family

ID=33395779

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05011671A MXPA05011671A (es) 2003-04-30 2004-04-29 Nuevos derivados de anilina, su manufactura y su uso como agentes farmaceuticos.

Country Status (20)

Country Link
US (1) US7205326B2 (es)
EP (1) EP1622896B1 (es)
JP (1) JP2006515347A (es)
KR (1) KR100763293B1 (es)
CN (1) CN100345845C (es)
AR (1) AR044098A1 (es)
AT (1) ATE366252T1 (es)
AU (1) AU2004234060A1 (es)
BR (1) BRPI0409951A (es)
CA (1) CA2522809A1 (es)
CL (1) CL2004000898A1 (es)
CO (1) CO5640050A2 (es)
DE (1) DE602004007374T2 (es)
ES (1) ES2290701T3 (es)
MX (1) MXPA05011671A (es)
NO (1) NO20054495L (es)
RU (1) RU2005137033A (es)
TW (1) TW200423931A (es)
WO (1) WO2004096796A1 (es)
ZA (1) ZA200508694B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200612914A (en) * 2004-03-05 2006-05-01 Hoffmann La Roche Novel oxidized thioether derivatives, their manufacture and use as pharmaceutical agents
FR2876692B1 (fr) 2004-10-19 2007-02-23 Sanofi Aventis Sa Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique
US20060116407A1 (en) * 2004-11-22 2006-06-01 Birgit Bossenmaier Amide derivatives
EP1915370A1 (en) * 2005-08-08 2008-04-30 F.Hoffmann-La Roche Ag Pyrazole derivatives, their manufacture and their use as pharmaceutical agents
CN112920133B (zh) * 2021-01-29 2022-09-16 中国医科大学 (e)-4-甲基-2-(4-(三氟甲基)苯乙烯基)噁唑类化合物及其制备方法与用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000065227A (ko) * 1996-07-19 2000-11-06 다께다 구니오 복소환 화합물, 그의 제조방법 및 용도
PE20011178A1 (es) 2000-04-07 2001-11-19 Takeda Chemical Industries Ltd Compuestos heterociclicos y su produccion

Also Published As

Publication number Publication date
US7205326B2 (en) 2007-04-17
ES2290701T3 (es) 2008-02-16
EP1622896A1 (en) 2006-02-08
NO20054495L (no) 2005-11-23
BRPI0409951A (pt) 2006-04-25
JP2006515347A (ja) 2006-05-25
CL2004000898A1 (es) 2005-03-04
DE602004007374D1 (de) 2007-08-16
AU2004234060A1 (en) 2004-11-11
AR044098A1 (es) 2005-08-24
NO20054495D0 (no) 2005-09-28
RU2005137033A (ru) 2006-06-27
KR20060006070A (ko) 2006-01-18
CN100345845C (zh) 2007-10-31
KR100763293B1 (ko) 2007-10-04
CN1780830A (zh) 2006-05-31
US20040254217A1 (en) 2004-12-16
ATE366252T1 (de) 2007-07-15
WO2004096796A1 (en) 2004-11-11
DE602004007374T2 (de) 2008-03-20
CA2522809A1 (en) 2004-11-11
TW200423931A (en) 2004-11-16
CO5640050A2 (es) 2006-05-31
ZA200508694B (en) 2007-06-27
EP1622896B1 (en) 2007-07-04

Similar Documents

Publication Publication Date Title
TW200730502A (en) Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents
TW200635923A (en) Tricyclic heterocycles, their manufacture and use as pharmaceutical agents
WO2006066913A3 (en) Benzamide substituted imidazo- and pyrolo-pyridines as protein kinase inhibitors
MX2009002010A (es) Derivados de heteroarilo como inhibidores de la proteina cinasa.
TW200624431A (en) Phthalazinone derivatives, their manufacture and use as pharmaceutical agents
SE0104140D0 (sv) Novel Compounds
TW200508214A (en) Novel compounds
SE0202539D0 (sv) Compounds
SE0200920D0 (sv) Novel compounds
WO2006066914A3 (en) Carbamate substituted imidazo- and pyrrolo-pyridines as protein kinase inhibitors
TW200531688A (en) Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
TW200639156A (en) New compounds
IL191748A0 (en) 7h-pyrido[3,4-d]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors
ATE499372T1 (de) Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel
MX2008011769A (es) Derivados de ftalazinona pirazol, su fabricacion y uso como agentes farmaceuticos.
IL198630A0 (en) Pyrimidyl derivatives as protein kinase inhibitors
TW200719899A (en) Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents
SE0202693D0 (sv) Compounds
MXPA05011671A (es) Nuevos derivados de anilina, su manufactura y su uso como agentes farmaceuticos.
TW200510370A (en) Urea derivatives
TW200505913A (en) Novel oxazole derivatives, their manufacture and use as pharmaceutical agents
SE0202692D0 (sv) Compounds
MY139613A (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
TW200602329A (en) Novel diazine derivatives, their manufacture and use as pharmaceutical agents
WO2005016921A3 (en) Novel oxazoles, their manufacture and use as pharmaceutical agents

Legal Events

Date Code Title Description
FG Grant or registration